Lloyd Sems

Insider Reports History

Entity
Individual
Location
C/O Sems Capital, 7 Dey Street, Suite 1101, New York, NY
Signature
/s/ Lloyd Sems
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lloyd Sems:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Director Common Stock 18.2K $60.3K $3.32 Jun 14, 2022 Direct
Cyclacel Pharmaceuticals, Inc. Director Stock Option (right to buy) 31.6K Jun 14, 2022 Direct

Insider Reports Filed by Lloyd Sems

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYCC Cyclacel Pharmaceuticals, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 15, 2021 2 $0 4 Jun 17, 2021 Director